Furthermore, a substantial body of research has demonstrated that the MAPK-ERK1/2 and JNK1/2 pathways are activated during heart failure by various factors, including growth factors, advanced glycation end products (AGEs), and angiotensin II (Ang II). Here, AGT is linked to heart failure.